Abstract
Aims Cerebral metastases represent a significant obstacle in the treatment of patients with systemic malignancies, occurring in 10-30% of patients with cancer. Brain imaging in neuro-asymptomatic patients is advised for some malignancies but not for others. Our aim was to examine the incidence of cerebral metastases in patients with a new diagnosis of the primary malignancies that commonly spread to the brain, and relate this with the patients’ neurological symptoms, if any.
Highlights
Cerebral metastases represent a significant obstacle in the treatment of patients with systemic malignancies, occurring in 10-30% of patients with cancer
Brain imaging in neuro-asymptomatic patients is advised for some malignancies but not for others
Our aim was to examine the incidence of cerebral metastases in patients with a new diagnosis of the primary malignancies that commonly spread to the brain, and relate this with the patients’ neurological symptoms, if any
Summary
Relating neurological symptoms to cerebral metastases at the time of initial staging scan. From International Cancer Imaging Society Meeting and 15th Annual Teaching Course (ICIS 2015) London, UK. Aims Cerebral metastases represent a significant obstacle in the treatment of patients with systemic malignancies, occurring in 10-30% of patients with cancer. Brain imaging in neuro-asymptomatic patients is advised for some malignancies but not for others. Our aim was to examine the incidence of cerebral metastases in patients with a new diagnosis of the primary malignancies that commonly spread to the brain, and relate this with the patients’ neurological symptoms, if any
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
